Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.
Clinical trial NCT05216588 · COMPLETED
Trial details
- NCT number
- NCT05216588
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-26
- Primary completion
- 2023-11-03
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.